Literature DB >> 11195850

Photoreactivity of tiaprofenic acid and suprofen using pig skin as an ex vivo model.

Z Sarabia1, D Hernández, J V Castell, G M van Henegouwen.   

Abstract

The skin is repeatedly exposed to solar ultraviolet radiation. Photoreaction of drugs in the body may result in phototoxic or photoallergic side effects. Non-steroidal anti-inflammatory drugs, such as tiaprofenic acid (TPA) and the closely related isomer suprofen (SUP) are frequently associated with photosensitive disorders; they may mediate photosensitised damage to lipids, proteins and nucleic acids. Using ex vivo pig skin as a model, we investigated the photodegradation of TPA and SUP, and photobinding of these drugs to protein by means of HPLC analysis and drug-directed antibodies. Both with keratinocytes, which were first isolated from the pig skin and thereafter exposed to UVA and with keratinocytes which were isolated from pig skin after the skin was UVA exposed, time-dependent photodegradation of TPA and SUP was found, beside photoadduct formation to protein. The results of this work show that: (a) TPA and SUP were photodecomposed with similar efficiency; major photoproducts detected were decarboxytiaprofenic acid (DTPA) and decarboxysuprofen (DSUP), respectively. (b) Both drugs form photoadducts, as concluded from recognition by drug-specific antibodies. Pig skin appears to be a good model for studying the skin photosensitising potential of drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11195850     DOI: 10.1016/s1011-1344(00)00098-1

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  1 in total

1.  High-throughput screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites.

Authors:  Satomi Onoue; Masanori Ochi; Graham Gandy; Yoshiki Seto; Naoko Igarashi; Yukinori Yamauchi; Shizuo Yamada
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.